Abiopharma

News list

Director Lynch Christopher S. 🟢 acquired 6.6K shares of Corebridge Financial, Inc. (CRBG) Transaction Date: Jun 18, 2026 | Filing ID: 044635

Full text

News bot June 22, 2026, 8:14 p.m.
🔍 Lynch Christopher S. (Director)

Company: Corebridge Financial, Inc. (CRBG)

Report Date: 2026-06-18
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 6,553
Detailed Transactions and Holdings:
- Acquired 6,553 shares of Common Stock (Direct)
  Date: 2026-06-18 | Code: A | equity_swap_involved: 0 | shares_owned_after: 34,962.00 | transaction_form_type: 4 | Footnotes: F1, F2
Footnotes:
- F1: Reflects deferred stock units (DSUs) granted under the Corebridge Financial, Inc. 2022 Omnibus Incentive Plan exempt under Rule 16b-3. Each DSU represents a right to receive one share of common stock of the Issuer upon the director's termination of service.
- F2: Includes 34,962 DSUs.